Risk factors and the incidence of coronary artery disease in young middle-aged Japanese men: Results from a 10-year cohort study

Internal Medicine

Volumn 45, Issue 5, 2006, Pages 235-239

  Satoh, Hiroki ^a   Nishino, Tetsuo ^b   Tomita, Kazuo ^b   Saijo, Yasuaki ^a   Kishi, Reiko ^a   Tsutsui, Hiroyuki ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Medical Center   (Japan)

Author keywords

Coronary artery disease; Diabetes mellitus; Dyslipidemia; Risk factors

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ANGINA PECTORIS; ARTICLE; BLOOD ANALYSIS; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART INFARCTION; HUMAN; INCIDENCE; JAPAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; ANGINA PECTORIS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, HDL; CONFIDENCE INTERVALS; CORONARY ARTERIOSCLEROSIS; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS;

EID: 33645694100     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.45.1532     Document Type: Article

References (25)

1. Castelli WP. Epidemiology of coronary heart disease: The Framingham Study. Am J Med 76: 4-12, 1984.
2. Hubert HB, Feinleib M, Mc Namara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation 67: 968-977, 1983.
3. Washio M, Hayashi R. Fukuoka Heart Study Group. Past history of obesity (overweight by WHO criteria) is associated with an increased risk of nonfatal acute myocardial infarction: a case-control study in Japan. Circ J 68: 41-46, 2004.
4. Neaton JD, Wentworth D. for the Multiple Risk Factor Intervention Trial Research Group: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med 152: 56-64, 1992.
5. WHO: Reducing risks, promoting healthy life. The World Health Report 2002.
6. Sekikawa A, Satoh T, Hayakawa T, Ueshima H, Koller LH. Coronary heart disease mortality among men aged 35-44 years by prefecture in Japan in 1995-1999 compared with among white men aged 35-44 by state in the United States in 1995-1998: Vital statistics in recent birth cohort. Jpn Circ J 65: 887-892, 2001.
7. Imamura H, Izawa A, Kai R, et al. Trends over the last 20 years in the clinical background of young Japanese patients with coronary artery disease. Circ J 68: 186-191, 2004.
8. Fujishima M, Kiyohara Y, Kato I, et al. Diabetes and cardiovascular disease in a prospective population survey in Japan: The Hisayama Study. Diabetes 45: S14-16, 1996.
9. Kinjo K, Kimura Y, Shinzato Y, et al. An epidemiological analysis of cardiovascular disease in Okinawa, Japan. Hypertension Res 15: 111-119, 1992.
10. Iso H, Naito Y, Sato S, et al. Serum triglyceride and risk of coronary heart disease among Japanese men and women. Am J Epidemiol 153: 490-499, 2001.
11. WHO Expert Committee. Arterial Hypertension and Ischemic Heart Disease, Preventive Aspects. Geneva: WHO Technical Report Series No 231. 1962.
12. AHA Committee Report. A reporting system on patient evaluated for coronary artery disease. Circulation 51: 5-34, 1975.
13. SPSS Incorporration. 2003 SPSS Base 12.05J User's Guide, SPSS INC. Chicago; IL; 2003.
14. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronary-events rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Lancet 353: 1547-1547, 1999.
15. Menotti A, Blackburn H, Seccareccia F, et al. The relationship of chronic diseases to all-cause mortality risk: The Seven Countries Study. Ann Med 29: 135-141, 1997.
16. Konishi M, Iida M, Naito Y, et al. The trend of coronary heart disease and its risk factors based on epidemiological investigation. Jpn Circ J 51: 319-324, 1987.
17. Kannel WB, Castelli WP, Gordon T. Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study. Ann Intern Med 90: 85-91, 1979.
18. Castelli WP, Garrison RJ, Wilson PW, Abbott RD, Kalousdian S, Kannel WB, et al. Incidence of coronary heart disease and lipoprotein cholesterol levels: The Framingham Study. JAMA 256: 2835-2838, 1986.
19. Wakugami K, Iseki K, Kimura Y, et al. Relationship between serum cholesterol and the risk of acute myocardial infarction in a screened cohort in Okinawa, Japan. Jpn Circ J 62: 7-14, 1998.
20. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adults Treatment Panel III). JAMA 285: 2486-2497, 2001.
21. American Diabetes Association. Report of the expert committees on the diagnosis and classification of diabetes mellitus. Diabetes Care 20: 1183-1197, 1997.
22. Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease: four prospective American studies. Circulation 79: 8-15, 1989.
23. Stamler J, Wentworth D, Neaton JD, et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 256: 2823-2828, 1986.
24. Kannel WB. Framingham study insights into hypertensive risk of cardiovascular disease. Hypertens Res 18: 181-196, 1995.
25. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation 106: 3143-3421, 2002.